(Q44427243)

English

A randomized trial of aggressive lipid reduction for improvement of myocardial ischemia, symptom status, and vascular function in patients with coronary artery disease not amenable to intervention

scientific article published on April 15, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

A randomized trial of aggressive lipid reduction for improvement of myocardial ischemia, symptom status, and vascular function in patients with coronary artery disease not amenable to intervention (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

myocardial ischemia

1 reference

based on heuristic

inferred from title

4

object named as

Thomas H. Marwick

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12727577

29 December 2023

author name string

Robert Fathi

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Brian Haluska

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Leanne Short

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

1 April 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

15 April 2003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12727577

29 December 2023

full work available at URL

https://api.elsevier.com/content/article/PII:S0002934303000524?httpAccept=text/xml

1 reference

10.1016/S0002-9343(03)00052-4

https://api.crossref.org/works/10.1016/S0002-9343(03)00052-4

29 December 2023

https://api.elsevier.com/content/article/PII:S0002934303000524?httpAccept=text/plain

1 reference

10.1016/S0002-9343(03)00052-4

https://api.crossref.org/works/10.1016/S0002-9343(03)00052-4

29 December 2023

American Journal of Medicine

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

114

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

445-453

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Statin trials and goals of cholesterol-lowering therapy after AMI.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Benefits of lipid lowering on vascular reactivity in patients with coronary artery disease and average cholesterol levels: a mechanism for reducing clinical events?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Refractory angina pectoris in end-stage coronary artery disease: evolving therapeutic concepts.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Exercise standards. A statement for healthcare professionals from the American Heart Association. Writing Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Increased common carotid intima-media thickness. Adaptive response or a reflection of atherosclerosis? Findings from the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Direct myocardial revascularization and angiogenesis--how many patients might be eligible?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Effects of spinal cord stimulation on myocardial ischaemia during daily life in patients with severe coronary artery disease. A prospective ambulatory electrocardiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina; evaluation by(13)N-ammonia positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Close relation of endothelial function in the human coronary and peripheral circulations

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Cholesterol reduction improves myocardial perfusion abnormalities in patients with coronary artery disease and average cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900052-4

7 January 2021

Identifiers

10.1016/S0002-9343(03)00052-4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44427243&oldid=2040135023"